Table 1 Clinico-pathological characteristics of the patients in the whole series, and according to type of chemotherapy
Characteristics | No. of patients | Platinum-containing chemotherapy No. (%) | Platinum/paclitaxel containing chemotherapy No. (%) |
|---|---|---|---|
All cases | 68 | 39 | 29 |
Age (yrs) | Â | Â | Â |
   <60 | 43 | 22 (51.2) | 21 (48.8) |
   ≥60 | 25 | 17 (68.0) | 8 (32.0) |
FIGO Stage | Â | Â | Â |
   IIIC | 50 | 31 (62.0) | 19 (38.0) |
   IV | 18 | 8 (44.4) | 10 (55.6) |
Cytoreduction | Â | Â | Â |
RT <1 cm | 18 | 12 (66.7) | 6 (33.3) |
RT ≥1 cm | 50 | 27 (54.0) | 7 (14.0) |
Ascites | Â | Â | Â |
   No | 16 | 8 (50.0) | 8 (50.0) |
   Yes | 52 | 29 (55.8) | 23 (44.2) |
Histotype | Â | Â | Â |
   Serous | 54 | 32 (59.2) | 22 (40.7) |
   Endometrioid | 8 | 5 (62.5) | 3 (37.5) |
   Undifferentiated | 6 | 2 (33.3) | 4 (66.7) |
   Other | 3 | 2 (66.7) | 1 (33.3) |
Grade | Â | Â | Â |
   G1-2 | 10 | 8 (80.0) | 2 (20.0) |
   G3 | 53 | 30 (56.6) | 23 (43.4) |
   n.a. | 5 |  |  |
COX-2 | Â | Â | Â |
Negative | 36 | 19 (52.8) | 17 (47.2) |
Positive | 32 | 20 (62.5) | 12 (37.5) |